Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false answering member printed
creator	label
publisher	pref label
tabling member	label

Search

1124901

	human indexable
	published
	registered interest
	answer date	21/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 20:49:48
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 20:57:06 17/05/2019 11:39:05
	hansard heading	Nusinersen
	house id	2
	identifier	HL15576
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	17/05/2019 11:07:46
	question text	To ask Her Majesty's Government what discussions they have had with (1) NICE, (2) NHS England, and (3) Biogen, on a Managed Access Agreement for Spinal Muscular Atrophy treatment, Spinraza.
	session	2017/19
	session number	1
	tabling member printed	Baroness Thomas of Winchester
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15576
	type	WrittenParliamentaryQuestion
	uin	HL15576
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Baroness Blackwood of North Oxford
	creator	3785 label Biography information for Baroness Thomas of Winchester
	publisher	25277 pref label House of Lords
	tabling member	3785 label Biography information for Baroness Thomas of Winchester

1124902

	human indexable
	published
	registered interest
	answer date	21/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 20:49:49
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 20:57:08 17/05/2019 11:39:03
	hansard heading	National Institute for Health and Care Excellence
	house id	2
	identifier	HL15577
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	17/05/2019 11:07:46
	question text	To ask Her Majesty's Government when they estimate that NICE will publish the outcome of the NICE Evaluation Committee meeting held on 6 March.
	session	2017/19
	session number	1
	tabling member printed	Baroness Thomas of Winchester
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15577
	type	WrittenParliamentaryQuestion
	uin	HL15577
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Baroness Blackwood of North Oxford
	creator	3785 label Biography information for Baroness Thomas of Winchester
	publisher	25277 pref label House of Lords
	tabling member	3785 label Biography information for Baroness Thomas of Winchester

1125504

	human indexable
	published
	registered interest
	answer date	22/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 20:24:49
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/05/2019 20:25:40 22/05/2019 15:22:03
	hansard heading	Pneumococcal Diseases: Vaccination
	house id	2
	identifier	HL15599
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	22/05/2019 14:50:14
	question text	To ask Her Majesty's Government what assessment they have made of the recommendations by the Joint Committee on Vaccination and Immunisation to reduce the infant pneumococcal vaccination schedule from three doses to two.
	session	2017/19
	session number	1
	tabling member printed	Baroness Masham of Ilton
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15599
	type	WrittenParliamentaryQuestion
	uin	HL15599
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Baroness Blackwood of North Oxford
	creator	1850 label Biography information for Baroness Masham of Ilton
	publisher	25277 pref label House of Lords
	tabling member	1850 label Biography information for Baroness Masham of Ilton

1125505

	human indexable
	published
	registered interest
	answer date	22/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 20:24:50
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/05/2019 20:25:42 22/05/2019 15:22:05
	hansard heading	Pneumococcal Diseases: Vaccination
	house id	2
	identifier	HL15600
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	22/05/2019 14:50:14
	question text	To ask Her Majesty's Government what analyses they have conducted of the risks and benefits of reducing the infant pneumococcal vaccination schedule from 2+1 to 1+1; and whether they will publish the results any such analyses.
	session	2017/19
	session number	1
	tabling member printed	Baroness Masham of Ilton
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15600
	type	WrittenParliamentaryQuestion
	uin	HL15600
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Baroness Blackwood of North Oxford
	creator	1850 label Biography information for Baroness Masham of Ilton
	publisher	25277 pref label House of Lords
	tabling member	1850 label Biography information for Baroness Masham of Ilton

1125506

	human indexable
	published
	registered interest
	answer date	22/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 20:24:51
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/05/2019 20:25:44 22/05/2019 15:22:01
	hansard heading	HIV Infection: Vaccination
	house id	2
	identifier	HL15601
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	22/05/2019 14:50:46
	question text	To ask Her Majesty's Government what steps they are taking to improve vaccination coverage for people living with HIV.
	session	2017/19
	session number	1
	tabling member printed	Baroness Masham of Ilton
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15601
	type	WrittenParliamentaryQuestion
	uin	HL15601
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Baroness Blackwood of North Oxford
	creator	1850 label Biography information for Baroness Masham of Ilton
	publisher	25277 pref label House of Lords
	tabling member	1850 label Biography information for Baroness Masham of Ilton

1125517

	human indexable
	published
	registered interest
	answer date	22/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 20:25:06
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/05/2019 20:35:13 22/05/2019 15:26:01
	hansard heading	NHS: Migrant Workers
	house id	2
	identifier	HL15612
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	22/05/2019 14:54:38
	question text	To ask Her Majesty's Government what plans they have, if any, to increase the number of NHS staff recruited from EU member states after Brexit.
	session	2017/19
	session number	1
	tabling member printed	Lord Taylor of Warwick
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15612
	type	WrittenParliamentaryQuestion
	uin	HL15612
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Baroness Blackwood of North Oxford
	creator	1796 label Biography information for Lord Taylor of Warwick
	publisher	25277 pref label House of Lords
	tabling member	1796 label Biography information for Lord Taylor of Warwick

1124720

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	03/05/2019
	date tabled	03/05/2019
	ddp created	03/05/2019 14:10:32
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	03/05/2019 14:16:34 15/05/2019 17:07:01
	hansard heading	Idiopathic Pulmonary Fibrosis
	house id	1
	identifier	250788
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:35:47
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to improve (a) early diagnosis and (b) treatment of idiopathic pulmonary fibrosis.
	session	2017/19
	session number	1
	tabling member constituency	Stevenage
	tabling member printed	Stephen McPartland
	title	House of Commons Tabled Parliamentary Question 2017/19 250788
	type	WrittenParliamentaryQuestion
	uin	250788
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	4093 label Biography information for Stephen McPartland
	publisher	25259 pref label House of Commons
	tabling member	4093 label Biography information for Stephen McPartland

1124918

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 21:09:22
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 21:15:42 15/05/2019 16:46:06
	hansard heading	Haemophilia: Medical Treatments
	house id	1
	identifier	251321
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:14:44
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that haemophilia patients receive (a) appropriate access to physiotherapy, (b) a regular clinical review, and (c) tailored dosing of treatments in accordance with NHS England’s service specification.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 251321
	type	WrittenParliamentaryQuestion
	uin	251321
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1124919

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 21:09:25
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 21:15:45 15/05/2019 16:46:04
	hansard heading	Haemophilia: Medical Treatments
	house id	1
	identifier	251322
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:14:44
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the Commercial Medicines Unit’s national tender framework for factor VIII haemophilia products on patient access to extended half-life medicines.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 251322
	type	WrittenParliamentaryQuestion
	uin	251322
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1124920

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 21:09:29
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 21:15:49 15/05/2019 16:46:03
	hansard heading	Blood Diseases: Medical Treatments
	house id	1
	identifier	251323
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:14:44
	question text	To ask the Secretary of State for Health and Social Care, what steps he NHS England is taking to ensure that patients with bleeding disorders have adequate access to treatment options that meet individual patient need.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 251323
	type	WrittenParliamentaryQuestion
	uin	251323
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon